Patrick M Sweeney & Associates Inc. Invests $1.08 Million in Haleon plc (NYSE:HLN)

Patrick M Sweeney & Associates Inc. acquired a new position in Haleon plc (NYSE:HLN) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 131,635 shares of the company’s stock, valued at approximately $1,083,000. Haleon comprises approximately 1.0% of Patrick M Sweeney & Associates Inc.’s holdings, making the stock its 23rd largest position.

A number of other hedge funds and other institutional investors have also modified their holdings of HLN. Hexagon Capital Partners LLC lifted its position in shares of Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock worth $35,000 after buying an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in Haleon by 853.4% during the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock worth $39,000 after purchasing an additional 4,267 shares during the period. SRS Capital Advisors Inc. grew its holdings in Haleon by 456.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock valued at $45,000 after purchasing an additional 4,477 shares during the last quarter. NBC Securities Inc. bought a new position in shares of Haleon in the third quarter valued at approximately $82,000. Finally, Hoxton Planning & Management LLC acquired a new stake in shares of Haleon in the fourth quarter worth $85,000. Institutional investors own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HLN shares. Argus restated a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. HSBC assumed coverage on Haleon in a research note on Wednesday, April 17th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Haleon Price Performance

Shares of HLN traded down $0.14 during mid-day trading on Wednesday, reaching $8.19. The company had a trading volume of 7,062,765 shares, compared to its average volume of 5,499,861. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The company has a market capitalization of $37.40 billion, a P/E ratio of 27.77, a P/E/G ratio of 2.19 and a beta of 0.28. Haleon plc has a twelve month low of $7.70 and a twelve month high of $8.98. The company’s 50-day moving average is $8.34 and its 200-day moving average is $8.29.

Haleon Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date of this dividend is Thursday, March 14th. This represents a dividend yield of 1.8%. Haleon’s dividend payout ratio is presently 70.00%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.